by Nicolas Hulscher, MPH

Glioblastoma (GBM) remains one of the most aggressive and lethal human cancers, with a median survival of roughly 15 months despite surgery, radiation, and chemotherapy. In a newly published paper in BJC Reports titled, Attenuation of malignant phenotype of glioblastoma following a short course of the pro-oxidant combination of Resveratrol and Copper, researchers found a short, non-toxic oral intervention that simultaneously suppresses tumor proliferation, cancer hallmarks, immune checkpoints, and stemness — while activating intrinsic tumor cell death.

In a small but carefully controlled pre-surgical “window” study, human glioblastoma patients received resveratrol (5.6 mg) plus copper (560 ng) four times daily for an average of just ~12 days before tumor resection. Tumor tissue was then compared with untreated controls.

The results reveal a system-level attenuation of malignant phenotype: near-eradication of tumor-promoting cell-free chromatin particles (cfChPs)—accompanied by a ~31% reduction in tumor proliferation (Ki-67), suppression of nine cancer hallmarks and cancer stemness, simultaneous down-regulation of six immune checkpoints, and activation of intrinsic apoptosis, all within ~12 days.

This was not a marginal signal. It was a coordinated, system‑level biological shift in one of the deadliest cancers known:

Near‑Elimination of Tumor‑Promoting Cell‑Free Chromatin

Using confocal microscopy, investigators showed that glioblastoma tumors are saturated with extracellular DNA–histone complexes (cfChPs) — debris released from dying cancer cells that can enter neighboring cells and drive DNA damage, inflammation, immune evasion, and malignancy.

After short‑course resveratrol–copper treatment, these cfChPs were virtually absent from the tumor microenvironment. Quantitative analysis showed a highly significant reduction in extranuclear chromatin signal, indicating near‑eradication of this upstream oncogenic driver.

Large Reduction in Tumor Proliferation (Ki‑67)

Ki‑67 is a gold‑standard marker of how aggressively a tumor is dividing.

• Control tumors: 82.1% Ki‑67–positive cells

• R‑Cu treated tumors: 56.7% Ki‑67–positive cells

• p < 0.0001

This represents a ~31% reduction in actively dividing tumor cells after less than two weeks of treatment. A shift of this magnitude suggests a real down‑staging of biological aggressiveness, even in the absence of visible histologic remodeling.

Simultaneous Suppression of 9 Hallmarks of Cancer

The authors examined 15 biomarkers spanning nine canonical hallmarks of cancer (genomic instability, inflammation, angiogenesis, invasion, metabolic reprogramming, etc.).

• 13 of 15 biomarkers were significantly reduced

• Combined hallmark burden dropped by ~50–60%

• p < 0.0001 across the composite analysis

This intervention produced broad, coordinated suppression of malignant behavior.

Collapse of Multiple Immune Checkpoints — All at Once

Six immune checkpoints were assessed:

• PD‑1

• PD‑L1

• TIM‑3

• NKG2A

• CTLA‑4

• LAG‑3

All were significantly down‑regulated in treated tumors (p < 0.0001 overall). Importantly, five of these checkpoints were shown to be expressed on tumor‑infiltrating lymphocytes, confirming biological relevance.

Marked Reduction in Cancer Stemness

Cancer stem cells drive recurrence, resistance, and lethality in GBM.

Three stem cell markers were analyzed:

• CD133

• CD44

• SOX2

All showed highly significant reductions (p < 0.0001), with combined stemness burden dropping by roughly 50–60%.

Massive Transcriptomic Reprogramming

RNA‑seq revealed a distinct transcriptional state in R‑Cu–treated tumors:

• 955 differentially expressed genes

• 870 genes down‑regulated

• Clear clustering separating treated from untreated tumors.

In other words, the treatment didn’t just tweak one pathway — it reprogrammed how the tumor was behaving at the genetic level.

One of the most dramatic changes involved PVRIG-2P, a gene closely related to PD-L1, the immune-evasion signal many cancers use to hide from the immune system. This immune-evasion gene was shut down by millions-fold

Genes control how cancer grows, spreads, hides from immunity, and resists treatment. Seeing this many cancer-related genes switch off at once suggests the tumor’s aggressive programming was being actively dismantled, not merely slowed.

Strong Activation of Intrinsic Tumor Cell Death

Pathway analysis showed robust activation of apoptosis and coordinated cleanup mechanisms:

• Hallmark apoptosis: NES = 2.899, FDR = 0

• Proteasomal degradation pathways: NES up to 3.68

• Increased active caspase‑3

• Reduced Annexin V (consistent with efficient debris clearance)

In other words, after treatment:

• Cancer cells were signaling themselves to shut down and die

• The body’s cellular cleanup machinery was also switched on, breaking down and removing dead cancer cells efficiently

• Key markers showed that cancer cells were dying in an organized, controlled manner, not exploding or spilling toxic debris into surrounding tissue

CONCLUSION

After ~12 days of a non-toxic oral intervention (resveratrol plus copper), glioblastoma tumors demonstrated:

• Near-elimination of tumor-promoting chromatin debris (cfChPs)

• A marked reduction in tumor cell proliferation (Ki-67)

• Suppression of nine core hallmarks of cancer

• Simultaneous down-regulation of six immune checkpoints

• Significant loss of cancer stem cell markers

• Large-scale reprogramming of tumor gene expression

• Activation of organized, intrinsic tumor cell death with efficient cleanup

Together, these findings indicate that a short, non-toxic intervention can biologically “de-escalate” one of the most aggressive human cancers across multiple independent axes of malignancy.

The authors explicitly note that longer trials are urgently needed to determine whether prolonged treatment could push tumors toward a more benign phenotype or improve clinical outcomes.

Nicolas Hulscher, MPH

Epidemiologist and Foundation Administrator, McCullough Foundation

Support our mission: mcculloughfnd.org

Please consider following both the McCullough Foundation and my personal account on X (formerly Twitter) for further content.

 

IPAK-EDU is grateful to FOCAL POINTS (Courageous Discourse) as this piece was originally published there and is included in this news feed with mutual agreement. Read More